 Connection
Yuki Fujiwara to Hepatoblastoma
This is a "connection" page, showing publications Yuki Fujiwara has written about Hepatoblastoma.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.788 |
|
|
|
-
Adawy A, Yoshii D, Hirao H, Komohara Y, Fujiwara Y, Tomita M, Honda M, Han J, Liu Y, Yamada S, Yamamoto M, Hiyama E, Hibi T. Identification of CD7 as a novel biomarker of embryonal hepatoblastoma. Pediatr Surg Int. 2025 Dec 04; 42(1):30.
Score: 0.224
-
Hirao H, Adawy A, Li L, Yoshii D, Yano H, Fujiwara Y, Honda M, Harada M, Yamamoto M, Komohara Y, Hibi T. The expression analysis of SerpinB9 in hepatoblastoma microenvironment. Pediatr Surg Int. 2024 Feb 12; 40(1):55.
Score: 0.197
-
Adawy A, Li L, Hirao H, Irie T, Yoshii D, Yano H, Fujiwara Y, Esumi S, Honda M, Suzu S, Komohara Y, Hibi T. Potential involvement of IL-32 in cell-to-cell communication between macrophages and hepatoblastoma. Pediatr Surg Int. 2023 Sep 26; 39(1):275.
Score: 0.192
-
Li L, Irie T, Yoshii D, Komohara Y, Fujiwara Y, Esumi S, Kadohisa M, Honda M, Suzu S, Matsuura T, Kohashi K, Oda Y, Hibi T. M-CSFR expression in the embryonal component of hepatoblastoma and cell-to-cell interaction between macrophages and hepatoblastoma. Med Mol Morphol. 2022 Sep; 55(3):236-247.
Score: 0.175
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|